Depression in Parkinson's Disease. The Impact of Symptom Overlap on Prevalence
Overview
Affiliations
The reported prevalence of depression concomitant with Parkinson's disease varies greatly in the literature, which may partly be explained by symptom overlap. To determine the impact of symptom overlap on the prevalence, the authors tested 100 Parkinson's disease patients for major depression (DSM-III-R) with both a standard, inclusive method and a diagnostic-etiologic, exclusive method. The authors found that the prevalence detected with the inclusive method (23%) decreased when the exclusive method was used (13%), which was mainly caused by lower scores on the item "loss of interest." The study's findings give empirical support for the relevance of the new category in DSM-IV "mood disorder due to a general medical condition."
Klimanova S, Radionov D, Shova N, Kotsyubinskaya Y, Yarygina Y, Berezina A Consort Psychiatr. 2025; 5(4):40-62.
PMID: 39980619 PMC: 11839218. DOI: 10.17816/CP15560.
Wan Z, Rasheed M, Li Y, Li Q, Wang P, Li J Mol Neurobiol. 2023; 60(10):5642-5654.
PMID: 37329382 DOI: 10.1007/s12035-023-03391-y.
Stocchi F, Antonini A, Barone P, Bellelli G, Fagiolini A, Strambi L Neurol Sci. 2023; 44(9):3123-3131.
PMID: 37100925 PMC: 10415449. DOI: 10.1007/s10072-023-06740-w.
Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano G, Alborghetti M Curr Neuropharmacol. 2019; 18(4):277-287.
PMID: 31622207 PMC: 7327944. DOI: 10.2174/1570159X17666191016094857.
Biological and Clinical Implications of Comorbidities in Parkinson's Disease.
Santiago J, Bottero V, Potashkin J Front Aging Neurosci. 2017; 9:394.
PMID: 29255414 PMC: 5722846. DOI: 10.3389/fnagi.2017.00394.